We are live on ! Find out more
EXEL icon

Exelixis

144 hedge funds and large institutions have $704M invested in Exelixis in 2016 Q1 according to their latest regulatory filings, with 22 funds opening new positions, 55 increasing their positions, 38 reducing their positions, and 22 closing their positions.

New
Increased
Maintained
Reduced
Closed

250% more call options, than puts

Call options by funds: $12.8M | Put options by funds: $3.66M

45% more repeat investments, than reductions

Existing positions increased: 55 | Existing positions reduced: 38

0% more funds holding in top 10

Funds holding in top 10: 22 (0)

0% more first-time investments, than exits

New positions opened: 22 | Existing positions closed: 22

1% less funds holding

Funds holding: 146144 (-2)

28% less capital invested

Capital invested by funds: $983M → $704M (-$279M)

Holders
144
Holders Change
-2
Holders Change %
-1.37%
% of All Funds
3.84%
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.05%
New
22
Increased
55
Reduced
38
Closed
22
Calls
$12.8M
Puts
$3.66M
Net Calls
+$9.16M
Net Calls Change
-$36K

EXEL Hedge Fund Activity: Q1 2016 in Review

144 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in Exelixis (EXEL) for Q1 2016, worth a combined $704M — down 28% from $983M a quarter earlier.

Fund positioning in EXEL was balanced in Q1 2016: 22 funds opened new positions, 22 closed out, 55 added to existing stakes and 38 trimmed.

The largest buyer was Baker Bros. Advisors, opening a new position worth an estimated $10.9M. The largest seller was Citadel Advisors, cutting an estimated $22.7M.

  • 144 institutional investors held Exelixis (EXEL) as of Q1 2016, down from 146 in Q4 2015.
  • Funds reported $704M of Exelixis stock for Q1 2016, down 28% quarter-over-quarter.
  • 22 funds opened new Exelixis positions in Q1 2016 and 22 closed out, a net change of 0 holders.
  • The largest Exelixis buyer in Q1 2016 was Baker Bros. Advisors, an estimated $10.9M added.
  • The largest Exelixis seller in Q1 2016 was Citadel Advisors, an estimated $22.7M sold.

Based on aggregated 13F filings for Q1 2016.